Precision Medicine – Page 2

Biotech Breakthroughs 2025: Emerging Trends and Technologies Shaping the Industry’s Future

5 months ago talkbio0Tagged Aortic Valve Insufficiency, Cancer Vaccines, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, Drug Discovery, Gene Modification, Investments, personalized therapies, Platform technologies, Precision Medicine, solid-state batteries

CRISPR therapeutics, solid-state batteries, precision medicine, AI in drug discovery, gene editing, cancer vaccines, personalized therapies, biotech investment, platform technologies, clinical trial innovation

World Cancer Day 2025: Innovations in Prevention, Detection, and Treatment

5 months ago talkbio0Tagged Aortic Valve Insufficiency, Cancer Research, Clinical Trials, Detection, Immunotherapy, Neoplasms, New, Precision Medicine

cancer research, immunotherapy, early detection, AI in oncology, novel therapies, clinical trials, personalized medicine

FDA Approves Roche’s PATHWAY HER2 Test for HER2-Ultralow Metastatic Breast Cancer

5 months ago talkbio0Tagged Approved, Biochemical Pathway, Carcinoma breast stage IV, Diagnosis, Enhertu, erbB-2 Receptor, HER2-ultralow, Pet Animal, Precision Medicine, Roche (company), United States Food and Drug Administration

Roche, PATHWAY HER2 (4B5) test, FDA approval, HER2-ultralow, metastatic breast cancer, companion diagnostic, Enhertu, personalized medicine

Biotech IPO Momentum: Maze and Metsera’s Dual Debut Signals Renewed Market Optimism

5 months ago talkbio0Tagged amsacrine/azacitidine/etoposide, biotech, IPO, IPOs, Market, Metsera, Obesity, Optimism, Precision Medicine, trends qualifier

Biotech IPOs, Maze Therapeutics, Metsera, obesity treatment, precision medicine, market optimism, 2025 IPO trends

Truveta Genome Project: A Historic 10M Genome Sequencing Initiative Backed by Regeneron, Illumina, and Leading Health Systems

6 months ago talkbio0Tagged Drug Discovery, genetic sequencing, genome sequencing, Genotype, healthcare analytics, Illumina, phenotypic, Precision Medicine, Regeneron, Truveta

Truveta Genome Project, 10M genome sequencing, Regeneron, Illumina, genetic sequencing, genotypic and phenotypic data, healthcare analytics, drug discovery, personalized medicine.

Biopharmaceutical Manufacturing and Emerging Trends in 2024: A Global Outlook

6 months ago talkbio0Tagged 2024, Biopharmaceutical manufacturing, Biosimilars, Biotechnology, Cells, Drug Discovery, gene therapy, innovations, Precision Medicine, trends qualifier

Biopharmaceutical manufacturing, 2024 trends, personalized medicine, AI-driven drug discovery, biosimilars, cell and gene therapies, biotechnology innovations.

Sanofi and Teva Pioneer Next-Generation IBD Treatment with Promising TL1A Antibody Results

7 months ago talkbio0Tagged Antibodies, Crohn 's disease, duvakitug, Gastrointestinal Diseases, Immunology, Inflammatory Bowel Diseases, Precision Medicine, TNFSF15 gene, Ulcerative Colitis

Inflammatory Bowel Disease (IBD), TL1A Antibody, Duvakitug, Crohn’s Disease, Ulcerative Colitis, Precision Medicine, Immunology, Gastrointestinal Diseases

Empowering Patients: The Key to Faster, More Impactful Research

7 months ago talkbio0Tagged Clinical Research, Empowerment, Engaged to be married, Health care facility, outcomes, Patient-Centered Care, Precision Medicine

Patient-centered care, Patient engagement, Personalized medicine, Clinical research, Healthcare outcomes, Patient empowerment

Maze Therapeutics Secures $115 Million Series D Funding to Advance Clinical-Stage Kidney Disease Programs

7 months ago talkbio0Tagged amsacrine/azacitidine/etoposide, APOL1 gene, Chronic Kidney Diseases, clinical-stage programs, Kidney Diseases, MZE782, MZE829, Precision Medicine, Series

Maze Therapeutics, Series D funding, kidney disease, clinical-stage programs, precision medicine, APOL1 kidney disease, chronic kidney disease, MZE829, MZE782.

IDEAYA Advances Cancer Pipeline with Biocytogen’s Bispecific ADC, Targeting B7H3/PTK7

8 months ago talkbio0Tagged B7H3/PTK7, Biocytogen, bispecific ADC, cancer pipeline, IDEAYA, Precision Medicine, therapeutic autologous dendritic cells

IDEAYA, Biocytogen, Bispecific ADC, B7H3/PTK7, Cancer Pipeline, Precision Medicine Oncology